Migraine Management, Volume 199 covers the effective treatment of migraines, including different subtypes of migraines in different patient populations. The classification and diagnostic criteria of common and uncommon subtypes of migraine is explored in detail, including childhood variants. An in-depth analysis of the pharmacology of acute and prophylactic agents is presented, along with an evidence-based review of pharmacologic management. This includes recently developed CGRP monoclonal antibodies and non-peptide small molecule CGRP antagonists. Advances in neuromodulatory treatments, both noninvasive and implantable are also critically reviewed.Finally, specific treatment-related issues in pregnancy and lactation and childhood as well as the elderly are covered. Issues related to the diagnosis and management of vestibular migraine and the co-morbid disorder of persistent postural-perceptual dizziness are also explored.
Development of Gluten-Free Pasta summarizes current progress in the development of gluten-free (GF) products, focusing particularly on pasta products. Presented in 11 chapters, the book focuses on the role of prebiotic fiber, hydrocolloids, fruit and vegetable by-product pomace and the physical, microstructural, sensory, and nutritional properties of the gluten-free pasta. The science of gluten intolerance is explained as well, with all relevant literature gathered and summarized in one place. Hence, this book lays a very solid foundation for the development of GF pasta which can be exploited as an essential therapeutic tool in the prevention of celiac disease. This comprehensive reference, written by world renowned scientists who elaborate on the study of different selected additives of plant origin, provides immense assistance in the field of research as many areas are still unexplored in the field of cereal science & technology.
Biocontamination Control for Pharmaceuticals and Healthcare, Second Edition outlines a biocontamination strategy that tracks bio-burden control and reduction at each transition in classified areas of a facility. The first edition of the book covers many of the aspects of the strategy, but the new official guidance signals that a roadmap is required to fully comply with its requirements. Completely updated with the newest version of the EU-GPM (EN17141), this new edition expands coverage of quality risk management and contains completely new examples to help professionals bridge the gap between regulation and implementation. This book offers professionals in pharma quality control and related areas guidance on building a complete biocontamination strategy.
The Microbiology, Pathogenesis, and Zoonosis of Milk Borne Diseases offers comprehensive coverage of milk-borne infection, diagnosis, and treatment. With a strong focus on milk hygiene, zoonotic diseases, and the pathogenesis of milk-borne microbial agents, this book discusses various pathogenic diseases, evaluates the severity of diseases from milk and milk products, and describes remedial measures after the application of drugs.This book also introduces the reader to the microbiology, pathogenesis, and zoonosis of milk-borne diseases. It not only describes the general aspects of milk-borne zoonosis and prevention, but also covers risk analysis, assessment, practice, and quality management in milk hygiene.In 22 chapters, The Microbiology, Pathogenesis, and Zoonosis of Milk Borne Diseases provides researchers, academicians, industry professionals, and students with a better understanding on how to assess zoonotic diseases from milk-borne pathogens and address their clinical manifestations.
Trends in Clinical Diseases, Production and Management of Goats, Two Volume Set examines goat diseases and their remedial measures after drug application. The book elaborates on disease and pathogenesis in a systematic way, describing disease evaluation, pathogenesis, identifications of pathogens and their severity to animals, exhibition of disease manifestation, and preventive and treatment strategies to counteract the aetiopathogenesis caused by pathogens. Further, the book gives insights on the microbial pathogenesis of goats, an overview of clinicals diseases of goats, and the impact on human health, aiming its content towards a broad audience, including microbiologists, veterinary scientists, and those working in the industry.
Frozen Shoulder: Present and Future provides insights into one of the most mysterious diseases of the human body, frozen shoulder, a condition characterized by severe shoulder pain and functional restriction of shoulder motion. About 4% of the general population develops a frozen shoulder, with numbers rising to 59% in patients with diabetes mellitus. It curiously only develops between the age of 40 and 60 years, affects more women than men, and seems to be more common in patients with sedentary jobs. Disease duration varies between 1 and 3 years and consequently has a large impact on health and economic well-being.
Advances in Clinical Chemistry, Volume 118, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry, including chapters on Advances in Endotoxin Analysis, Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance, Osteopontin in Cancer, Gastrointestinal Hormones: History, Biology, and Measurement, Natriuretic Peptide Testing Strategies in Heart Failure: a 2023 Update, and Defining Allowable Total Error Limits in the Clinical Laboratory.
New Insights, Trends and Challenges in the Development and Applications of Microbial Inoculants in Agriculture provides information about how to develop high-quality microbial inoculants (biofertilizers and biopesticides) for increasing crop yields and quality and reducing the economic, environmental and health costs of food production. The book's chapters discuss cutting-edge approaches and techniques to develop bioformulations as reliable, viable solutions for food production, including the importance of a legal framework to guarantee the quality and safety of these bio-products. Additionally, it provides information on the current limitations and future approaches to enhance microbial inoculant development for contributing to global food security. Interest in biofertilizers and the potential for their use in sustainable agriculture is increasing. However, many commercial bioproducts are low quality due to the lack of quality standards which causes a decrease in efficiency, high variability in the field, and loss of confidence from farmers.
MicroRNA in Human Infectious Diseases offers an overview of the therapeutic and diagnostic role microRNAs can play in treating infectious diseases. Beginning with an introduction on microRNAs and their mechanisms, the book then delves into the therapeutic role of microRNAs in various categories of diseases, including bacterial, viral, and parasitic. A wide range of diseases are explored, including STDs, typhoid, tuberculosis, Dengue fever, Ebola, Covid-19, Malaria, Leishmaniasis, and Lymphatic filariasis. The final section of the book covers microRNA-based system approaches, considering aspects such as web-based tools available for detecting and predicting microRNA targets and the latest technologies for modifying and manipulating microRNAs.This volume explores microRNA across a multitude of conditions and is an ideal reference for those involved in the investigation and development of treatments in this area.
Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions, Volume 21 highlights different strategies to reverse chemotherapy resistance in cervical cancer. The book puts a strong focus on strategies to reverse chemotherapy resistance as well as strategies for early detection of the resistance, enhancing precision oncology in terms of patient care and maximizing patient management. The book also looks at virally induced resistance to chemotherapy and recommends combination therapies that can maximize the reversal of this resistance.In 10 chapters, the book not only gives an overview of cervical cancer and chemotherapy as treatment, but also investigates resistance to chemotherapy and treatment for resistance. It defines treatment mechanisms, options, and limitations to beat chemotherapy resistance and the reversal of the resistance mechanisms. It gives insights into future directions of cervical cancer treatment using epigenetic silencing, chemotherapy splicing, the involvement of MicroRNAs to chemotherapy resistance, and the application of Artificial Intelligence.